However, that's being overshadowed by the forearm injury to star right fielder Juan Soto. During the 8-5 win over the Minnesota Twins on Thursday night, capping their second consecutive series ...

New York Yankees right fielder Juan Soto exited Thursday night's contest against the Minnesota Twins due to left forearm discomfort, the team announced. After the game, Yankees manager Aaron Boone ...

NEW YORK-- New York Yankees slugger Juan Soto is day-to-day with left forearm inflammation, the Yankees announced Friday. Soto left Thursday night's game against the Minnesota Twins with forearm ...

But that wasn’t the case Thursday night. Not with superstar outfielder Juan Soto needing imaging after persistent discomfort in his left forearm. “I think everyone’s a little concerned ...

Jon Heyman of the New York Post reported Friday that the initial prognosis for Yankees star Juan Soto is that he is only dealing with inflammation in his left forearm and is expected to be OK.

Juan Soto is scheduled for an MRI on Friday, due to lingering left forearm discomfort. UPDATE:Following MRI, Yankees address Juan Soto's status vs. Dodgers After the Yankees’ 8-5 win Thursday ...

As more and more of us work from home, it’s important to have the best ergonomic office chair that will enhance and support good posture. Of course, you want the chair to be comfortable but you ...

The best office chairs can help elevate your day to day working experience whether you’re working from home or are back in the office. They make sitting at a desk all day long a much more ...

However, not all hand trucks are created equal. The quest for the most ergonomic and comfortable options is not just about improving productivity; it's also about reducing strain and the risk of ...

NEW YORK -- The Yankees have received what manager Aaron Boone described as “good news” regarding Juan Soto, as an MRI of the outfielder’s ailing left forearm taken on Friday afternoon revealed ...

(The Hill) — The expert advisory panel for the Food and Drug Administration (FDA) unanimously voted on Wednesday in favor of selecting the JN.1 COVID-19 subvariant to be targeted by the next ...